Concept
Troponin and cardiovascular disease in relation to COVID-19
- Troponin found circulation in the heart is an indicator of a myocardial injury
- Myocardial injury causes inflammation
- Troponin levels are elevated in COVID-19 patients
- Mortality rates of those with COVID-19 are greater in those with cardiovascular disease
- COVID-19 patients experiencing ARDS are at greater risk of developing nonischemic myocardial injury and type 2 myocardial infarction
0
0
Updated 2021-02-21
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Disability Studies
Social Science
Empirical Science
Science
Related
Factors that can potentially increase ACE2 expression in the Cardiovascular System
Inhibitors of the Renin–Angiotensin–Aldosterone System (RAAS) and COVID-19
Studying the effect of ACE inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) in COVID-19 Patients with Hypertension (Wuhan, China)
Troponin and cardiovascular disease in relation to COVID-19